Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
+56,25% in 5 Tagen: Genialer Schachzug - diese Übernahme verändert alles
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
48 Leser
Artikel bewerten:
(0)

Asia Breast Cancer Screening (Mammography, MRI & Ultrasound) Market, 2022 - Market Size is Expected to Cross Over US$ 4 Billion

DUBLIN, July 11, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Asia Breast Cancer Screening Market Forecast (Mammography, MRI & Ultrasound)" report to their offering.

Logo

Asia breast cancer screening market size is expected to cross over US$ 4 Billion by 2022

China, Japan and Korea are the top most contributors. Increasing breast cancer awareness, government and NGOs support breast cancer screening programs and ageing women population are major driving forces for this market. Key threats for breast cancer market in Asia are societal fear, misconceptions and cultural barriers for Breast Cancer Screening. Other major challenge being faced by almost all Asian countries is non availability of national level screening program; however partial or regional screening programs are available in few of these countries.

China is clear winner in the Asia breast cancer screening market. It controls nearly three fourth of the total screening market due to its large women population. Despite poor awareness about breast cancer screening, government partial screening programs and Global as well as domestic NGOs initiatives is helping China to become leader in the Asian breast cancer screening market.

Mammogram is leading methods for the breast cancer screening in the Asian countries. Other popular available methods are MRI and Ultrasound. China, Japan and Korea are top three countries for breast cancer mammogram screening. Their combined share was over 90 percent in 2016. India, Singapore, Malaysia and Thailand are other market for breast cancer mammogram screening.


All the 7 countries in the report have been studied from 7 viewpoints:

- Asia Breast Cancer Screening Market and Forecast
- Asian Countries Breast Cancer Mammography Screening Population Numbers and Forecast
- Asian Countries Breast Cancer MRI & Ultrasound Screening Population Numbers and Forecast
- Asian Countries Breast Cancer Mammography Screening Market and Forecast
- Asian Countries Breast Cancer MRI Screening Market and Forecast
- Asian Countries Breast Cancer Ultrasound Screening Market and Forecast
- Asian Countries Breast Cancer Screening Market and Forecast

7 Asian Countries Studied in the Report are as Follows:

1. India
2. China
3. Japan
4. Korea
5. Singapore
6. Thailand
7. Malaysia

For more information about this report visit https://www.researchandmarkets.com/research/mh6s56/asia_breast

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.